Description

Carbamic Acid, n-[3-[[1-Oxo-5-[[3,4,6-Tri-o-Acetyl-2-(Acetylamino)-2-Deoxy-β-D-Galactopyranosyl]Oxy]Pentyl]Amino]Propyl]-, Phenylmethyl Ester is a sophisticated, high-purity synthetic intermediate characterized by its complex carbohydrate-derived structure. This compound is of significant value for research and development in advanced pharmaceutical synthesis, particularly in the creation of novel glycoconjugates and targeted therapeutics. It serves as a critical building block for medicinal chemists and process development scientists working in biopharmaceuticals, oncology research, and advanced drug delivery systems.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of complex glycopeptides, glycoproteins, and carbohydrate-based drug candidates.
• Glycoconjugate Research: Used in the development of novel vaccine adjuvants, antibody-drug conjugates (ADCs), and targeted cancer therapies.
• Enzyme Inhibitor Synthesis: Serves as a scaffold for creating selective inhibitors of glycosidases and other carbohydrate-processing enzymes.
• Bioconjugation Chemistry: Employed in linking bioactive molecules to carriers or labels via its reactive functional groups for diagnostic and therapeutic applications.
• Chemical Biology Probes: Utilized in the design and synthesis of activity-based probes to study glycosylation pathways and related biological processes.
• Process Development: Acts as a reference standard and a critical material for scaling up the production of advanced therapeutic entities under cGMP conditions.

Basic Information

Product Name	Carbamic Acid, n-[3-[[1-Oxo-5-[[3,4,6-Tri-o-Acetyl-2-(Acetylamino)-2-Deoxy-β-D-Galactopyranosyl]Oxy]Pentyl]Amino]Propyl]-, Phenylmethyl Ester
CAS No.	1637413-95-6
Molecular Formula	C34H49N3O13
Molecular Weight	707.77 g/mol
Synonyms	Benzyl N-[3-({5-[(2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-β-D-galactopyranosyl)oxy]pentanoyl}amino)propyl]carbamate; GalNAc(Ac)3-C5-NH-Cbz; N-[(3-{[(Benzyloxy)carbonyl]amino}propyl)carbamoyl]-5-{[2-(acetylamino-3,4,6-tri-O-acetyl-2-deoxy-β-D-galactopyranosyl]oxy}pentanamide; Cbz-NH-(CH2)3-NH-CO-(CH2)4-O-GalNAc(Ac)3; Glycosylated Cbz-Protected Linker; 1637413-95-6
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to stringent quality protocols to ensure batch-to-batch consistency and purity suitable for research and pre-clinical development. Each lot is supported by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles. While produced under controlled conditions, specifications can be aligned with research-grade or cGMP-grade requirements based on customer needs. Certificates of Analysis (COA) are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below in a desiccated environment. For long-term storage under inert atmosphere, sealing under argon or nitrogen is recommended. Allow the sealed container to reach room temperature before opening to minimize moisture condensation.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 1.0%
Residual Solvents (GC)	Meets ICH Q3C guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.